CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE Mark
3.3.3 Ministry of Health, Labor and Welfare (MHLW)
3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.7 Porters Five Forces analysis
3.8 Market dynamics
3.8.1 Drivers
3.8.1.1 Rising incidence of chronic diseases
3.8.1.2 Technological advancements
3.8.1.3 Increase in out of pocket expenses
3.8.2 Restraints
3.8.2.1 Unstable reimbursement regulations
3.8.2.2 Limited awarenesS
3.8.3 Market Opportunities
3.8.3.1 Lucrative opportunities in emerging markets
3.8.3.2 Undifferntiated products
CHAPTER 4 WORLD REMOTE PATIENT MONITORING MARKET, BY CONDITION
4.1 Overview
4.1.1 Market size and forecast
4.2 Congestive heart failure (CHF)
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Diabetes
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Chronic obstructive pulmonary disease (COPD)
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.5 Blood pressure monitoring
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.6 Mental health
4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.7 Others
4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast
CHAPTER 5 WORLD REMOTE PATIENT MONITORING MARKET, BY COMPONENTS
5.1 Overview
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Market size and forecast
5.3 Software
5.3.1 Market size and forecast
CHAPTER 6 WORLD REMOTE PATIENT MONITORING MARKET, BY GEOGRAPHY
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 Market size and forecast
6.2.5 U.S.
6.2.6 Canada
6.2.7 Mexico
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Market size and forecast
6.3.5 Germany
6.3.6 France
6.3.7 U.K.
6.3.8 Italy
6.3.9 Spain
6.3.10 Russia
6.3.11 Rest of Europe
6.4 Asia Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Market size and forecast
6.4.5 Japan
6.4.6 China
6.4.7 Australia
6.4.8 India
6.4.9 South Korea
6.4.10 Taiwan
6.4.11 Rest of Asia-Pacific
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Market size and forecast
6.5.5 Brazil
6.5.6 Turkey
6.5.7 Venezuela
6.5.8 Saudi Arabia
6.5.9 Republic of South Africa
6.5.10 Rest of LAMEA
CHAPTER 7 COMPANY PROFILES
7.1 Aerotel Medical Systems (1988) Ltd.
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
1.1.4 Key strategic moves & developments
7.2 Biotronik SE & Co. KG
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Key strategic moves & developments
7.3 Boston Scientific Corporation
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategic moves & developments
7.4 General Electric Company
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Key strategic moves & developments
7.5 Nihon Kohden Corporation
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves & developments
7.6 Medtronic Plc
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 Key strategic moves & developments
7.7 Masimo Corporation
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key strategic moves & developments
7.8 Abbott Laboratories
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key strategic moves & developments
7.9 Johnson and Johnson
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key strategic moves & developments
7.10 Omron Corporation
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Key strategic moves & developments
Other players in the RPM market include (profiles not included in the report)
A&D Company, Limited
Aipermon GmbH & Co. KG
Jawbone
Docobo Ltd.
Microlife Corporation
Schiller AG
SHL Telemedicine
Sorin Group